Understanding the V122I Gene Variant
The V122I gene variant is a specific change in the transthyretin (TTR) gene. Variants in this gene are associated with hereditary ATTR amyloidosis, a condition that can lead to amyloid deposits in organs such as the heart and nerves.
Researchers have identified more than 100 variants of the TTR gene. Each variant can influence how the transthyretin protein behaves in the body. The V122I variant is one of the variants most closely linked to hereditary ATTR disease that affects the heart.
Understanding this variant has become an important part of improving awareness of hereditary ATTR amyloidosis and helping families recognize potential patterns of disease.
What Does V122I Mean?
The name V122I describes a change in the structure of the transthyretin protein.
Proteins are made up of building blocks called amino acids. At position 122 in the transthyretin protein, the amino acid valine (V) is replaced with isoleucine (I).
Although this change is small, it can affect how stable the protein is. Over time, this instability may allow amyloid deposits to form.
Scientists use this naming system to identify and study specific genetic variants.
How Common Is the V122I Variant?
The V122I variant has been identified in individuals with ancestry connected to West Africa. Because of historical population patterns, the variant is also present in some Black American communities.
Researchers estimate that about 3–4% of African Americans carry the V122I variant, which is roughly 1 in 25 individuals.
Carrying the variant does not mean someone will automatically develop hereditary ATTR amyloidosis. However, it may increase the risk of developing ATTR-related disease later in life, particularly forms that affect the heart and/or nerves.
Because hereditary ATTR amyloidosis is a genetic condition, variants such as V122I can also be passed through families. Understanding whether the variant is present in a family can help individuals recognize possible patterns of illness across generations.
Growing awareness of the V122I variant has helped researchers and clinicians better recognize hereditary ATTR disease in populations where it was previously underdiagnosed.
Why Awareness of V122I Matters
Learning about genetic variants such as V122I can help individuals and families better understand possible health risks and recognize patterns of illness that may occur across generations.
In some families, relatives may have experienced heart disease or other symptoms without knowing there could be a genetic connection.
Increasing awareness helps people ask informed questions about family health history and discuss potential concerns with healthcare providers.
Awareness also supports conversations within families and communities about hereditary disease, education, and early recognition.
Understanding the Language of V122I
Medical information can sometimes include unfamiliar words.
Below are a few key terms that may help explain the V122I variant.
-
V122I is a specific variant of the transthyretin (TTR) gene. The name describes a change in the transthyretin protein where the amino acid valine (V) is replaced by isoleucine (I) at position 122.
-
A genetic variant is a small difference in a gene’s code. Many variants do not affect health, but some can change how a protein behaves in the body.
-
Amino acids are the building blocks that make up proteins. Proteins are made by linking many amino acids together in a specific order.
Learn More About Hereditary ATTR Amyloidosis
The V122I variant is one part of the larger story of hereditary ATTR amyloidosis. Understanding how this condition develops in the body can help individuals and families recognize potential signs and seek reliable information.
If you would like to learn more about the condition itself, visit:
Awareness often begins with a conversation… within families, communities, and across generations.